Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno

Showing results (171-180 of 778) with videos related to

Pageof 78
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 13, 2012
Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgmentDavide Capodanno, Valeria Calvi, Corrado Tamburino
International Journal of Cardiology|September 16, 2011
A focused update on emerging prognostic determinants in distal left main percutaneous coronary interventionDavide Capodanno, Valeria Calvi, Corrado Tamburino
International Journal of Cardiology|November 10, 2009
Sirolimus- vs. paclitaxel-eluting stents in patients undergoing off-label percutaneous coronary interventionCettina Ruperto, Davide Capodanno, Corrado Tamburino
Recent Patents on Cardiovascular Drug Discovery|April 20, 2013
Current status and ongoing development of reversing agents for novel oral anticoagulants (NOACs)Davide Capodanno, Giuseppe Giacchi, Corrado Tamburino
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 26, 2020
Unmasking psychological reasons of delay in acute coronary syndromes presentation during the COVID-19 pandemicAntonio Greco, Marco Spagnolo, Davide Capodanno
Expert Review of Cardiovascular Therapy|September 18, 2025
Anti-inflammatory strategies for patients with atherosclerotic coronary diseaseAntonino Imbesi, Antonio Greco, Davide Capodanno
Expert Opinion on Pharmacotherapy|January 21, 2011
The optimal pharmacological formula for percutaneous coronary interventionDavide Capodanno, Corrado Tamburino, George Dangas
International Journal of Cardiology|May 31, 2015
Five-year outcomes of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with left main coronary artery disease: An updated meta-analysis of randomized trials and adjusted observational studiesGiuseppe Gargiulo, Corrado Tamburino, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 7, 2022
What is the future role of cerebral embolic protection in transcatheter aortic valve implantation?Lars Sondergaard, Darren Mylotte, Davide Capodanno
Reviews on Recent Clinical Trials|March 5, 2010
Clinical development of selective anticoagulants: a state of the artPiera Capranzano, Davide Capodanno, Corrado Tamburino
Pageof 78

Showing results (171-180 of 778) with videos related to

Sort By:
Pageof 78
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 13, 2012
Effect size of ticagrelor over clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial: from statistics to clinical judgmentDavide Capodanno, Valeria Calvi, Corrado Tamburino
International Journal of Cardiology|September 16, 2011
A focused update on emerging prognostic determinants in distal left main percutaneous coronary interventionDavide Capodanno, Valeria Calvi, Corrado Tamburino
International Journal of Cardiology|November 10, 2009
Sirolimus- vs. paclitaxel-eluting stents in patients undergoing off-label percutaneous coronary interventionCettina Ruperto, Davide Capodanno, Corrado Tamburino
Recent Patents on Cardiovascular Drug Discovery|April 20, 2013
Current status and ongoing development of reversing agents for novel oral anticoagulants (NOACs)Davide Capodanno, Giuseppe Giacchi, Corrado Tamburino
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 26, 2020
Unmasking psychological reasons of delay in acute coronary syndromes presentation during the COVID-19 pandemicAntonio Greco, Marco Spagnolo, Davide Capodanno
Expert Review of Cardiovascular Therapy|September 18, 2025
Anti-inflammatory strategies for patients with atherosclerotic coronary diseaseAntonino Imbesi, Antonio Greco, Davide Capodanno
Expert Opinion on Pharmacotherapy|January 21, 2011
The optimal pharmacological formula for percutaneous coronary interventionDavide Capodanno, Corrado Tamburino, George Dangas
International Journal of Cardiology|May 31, 2015
Five-year outcomes of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with left main coronary artery disease: An updated meta-analysis of randomized trials and adjusted observational studiesGiuseppe Gargiulo, Corrado Tamburino, Davide Capodanno
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 7, 2022
What is the future role of cerebral embolic protection in transcatheter aortic valve implantation?Lars Sondergaard, Darren Mylotte, Davide Capodanno
Reviews on Recent Clinical Trials|March 5, 2010
Clinical development of selective anticoagulants: a state of the artPiera Capranzano, Davide Capodanno, Corrado Tamburino
Pageof 78